The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis

被引：0
|
作者：
Iacoviello, L [1 ]
Burzotta, F
Di Castelnuovo, A
Zito, F
Marchioli, R
Donati, MB
机构：
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharm,Un Gen Vasc Risk Fact, I-66030 Santa Maria Imbaro, Italy
[2] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Lab Clin Epidemiol Cardiovasc Dis, I-66030 Santa Maria Imbaro, Italy
[3] TNO, PG, Gaubius Lab, Leiden, Netherlands
来源：
THROMBOSIS AND HAEMOSTASIS | 1998年 / 80卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [31] Increased PAI-1 plasma levels and risk of death from dengue: No association with the 4G/5G promoter polymorphism
    Mairuhu A.T.A.
    Setiati T.E.
    Koraka P.
    Hack C.E.
    Leyte A.
    Faradz S.M.H.
    ten Cate H.
    Brandjes D.P.M.
    Osterhaus A.D.M.E.
    Reitsma P.H.
    van Gorp E.C.M.
    Thrombosis Journal, 3 (1)
  • [32] Association of a common polymorphism in the a-subunit gene of factor XIII with myocardial infarction and stroke. Interactions with PAI-1 levels and PAI-1 4G/5G genotype
    Kohler, HP
    Catto, AJ
    Stickland, MH
    OsseiGerning, N
    Carter, A
    Mikkola, H
    Grant, PJ
    THROMBOSIS AND HAEMOSTASIS, 1997, : HI15 - HI15
  • [33] PAI-1 promoter 4G/5G polymorphism and fibrinolytic potential in patients with deep vein thrombosis
    Sartori, MT
    Vettore, S
    Radossi, P
    Danesin, C
    Pontarollo, S
    Patrassi, GM
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS398 - PS398
  • [34] Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis
    Peres Wingeyer, Silvia
    de Larranaga, Gabriela
    Fontana, Laura
    Cunto, Eleonora
    Nogueras, Cristina
    San Juan, Jorge
    THROMBOSIS RESEARCH, 2010, 125 (04) : 367 - 369
  • [35] The PAI-1 promoter 4G/5G polymorphism does not associate with complications in type 2 diabetes
    Lucchesi, D
    Pucci, L
    Bandinelli, S
    Pilo, M
    Stellini, D
    Giannarelli, R
    del Prato, S
    Penno, G
    DIABETES, 2001, 50 : A177 - A177
  • [36] Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer
    Blasiak, J
    Smolarz, B
    ACTA BIOCHIMICA POLONICA, 2000, 47 (01) : 191 - 199
  • [37] 4G/5G polymorphism in the promoter region of the PAI-1 gene is not a risk factor for familial myocardial infarction: A case-control study in a sample of GISSI-2 patients
    Burzotta, F
    DiCastelnuovo, A
    DOrazio, A
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS388 - PS388
  • [38] Induction of PAI-1 synthesis by growth factors in human arterial smooth muscle cells is independent of the 4G/5G polymorphism in the promoter of the PAI-1 gene
    Nordt, TK
    Esohenfelder, E
    Ruef, J
    Peter, K
    Sobel, BE
    Bode, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 280A - 280A
  • [39] PAI-1 4G/5G POLYMORPHISM IN PATIENTS WITH SPLANCHNIC VEIN THROMBOSIS
    Kumar, Narender
    Kollabathula, Arpitha
    Jamwal, Manu
    Ahluwalia, Jasmina
    Das, Reena
    Varma, Neelam
    Rana, Surinder K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 95 - 95
  • [40] Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance
    Sartori, MT
    Vettor, R
    De Pergola, G
    De Mitrio, V
    Saggiorato, G
    Della Mea, P
    Patrassi, GM
    Lombardi, AM
    Fabris, R
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1161 - 1169
12345